Cost/ Benefit Aspects on Thromboprophylaxis
- 1 January 1993
- journal article
- research article
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 23 (Suppl. 1) , 15-19
- https://doi.org/10.1159/000216904
Abstract
Several studies have shown thromboprophylaxis of any kind to be more cost-effective than no prophylaxis or general diagnostic surveillance and selective treatment. Little has been written on low molecular weight heparins from the cost-effectiveness point of view. This preliminary study shows low molecular weight heparin to be more cost-effective than standard low-dose heparin in most situations of prophylaxis.Keywords
This publication has 0 references indexed in Scilit: